Nuveen »

Prelude Therapeutics shares owned by Nuveen

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Nuveen

Quarter filed Position value Share count Share price at filing
2026-06-30 $197k 37k 5.33
2025-03-31 $3.6M 188k 19.28

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Advanced Micro Devices (AMD)

View all positions for Nuveen

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
RA Capital Management
Soleus Capital Management
Kynam Capital Management
Vanguard Capital Management
BlackRock
Sphera Funds Management
Two Sigma Investments
ADAR1 Capital Management
Millennium Management
Geode Capital Management
Adage Capital Partners GP
Acadian Asset Management
Morgan Stanley

View all funds holding Prelude Therapeutics